Spero Therapeutics (SPRO)
(Delayed Data from NSDQ)
$2.17 USD
-0.09 (-3.98%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $2.14 -0.03 (-1.38%) 5:34 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Spero Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
SPRO 2.17 -0.09(-3.98%)
Will SPRO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SPRO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SPRO
Bayer Begins Phase I/II Study on Cell Therapy for Eye Disease
AZN's Imfinzi Wins EU Nod for Muscle-Invasive Bladder Cancer
SPRO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Vertex Gets EU Nod for New Cystic Fibrosis Drug Alyftrek
RCKT's IND for RP-A701 in Dilated Cardiomyopathy Gets FDA Clearance
ABBV to Boost Immunology Pipeline With Capstan Buyout for $2.1B
Other News for SPRO
Rare Stock Picks In June 2025 - From 26 Discerning Analysts
Spero Therapeutics Increases Stock Incentive Plan Shares
Spero Therapeutics -- Additional Upside Potential Following Positive Phase 3 Results
TD Cowen Remains a Hold on Spero Therapeutics (SPRO)
Largest borrow rate increases among liquid names